Cargando…

Antithrombin III expression predicts acute kidney injury in elderly patients with sepsis

Elderly people represent the age group most frequently affected by acute kidney injury (AKI). The potential of Antithrombin III (ATIII) level for predicting AKI among elderly patients with sepsis is yet to be elucidated. Therefore, the purpose of the present study was to evaluate the ability of ATII...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Yun, Tian, Rui, Jin, Wei, Xie, Hui, Du, Jiang, Zhou, Zhigang, Wang, Ruilan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966107/ https://www.ncbi.nlm.nih.gov/pubmed/32010265 http://dx.doi.org/10.3892/etm.2019.8305

Ejemplares similares

Fibrinogen and antithrombin III are associated with in-hospital mortality among critically ill patients with acute kidney injury
por: Zhang, Guangyuan, et al.
Publicado: (2022)

Antithrombin III concentrate therapy may have an efficacy in sepsis
por: Saito, N, et al.
Publicado: (2013)

The Association between the Level of Antithrombin III and Mortality in Children with Sepsis
por: Lestari, Indah Nur, et al.
Publicado: (2019)

[Corrigendum] Role of Thrombospondin‑1 in sepsis‑induced myocardial injury
por: Xie, Yun, et al.
Publicado: (2023)

Antithrombin in sepsis revisited
por: Levi, Marcel
Publicado: (2005)

Low Preoperative Antithrombin III Level Is Associated with Postoperative Acute Kidney Injury after Liver Transplantation
por: Kim, Kyoung-Sun, et al.
Publicado: (2021)

The effect of recombinant human thrombopoietin (rhTPO) on sepsis patients with acute severe thrombocytopenia: a study protocol for a multicentre randomised controlled trial (RESCUE trial)
por: Zhou, Zhigang, et al.
Publicado: (2019)

Antithrombin III prevents progression of chronic kidney disease following experimental ischaemic‐reperfusion injury
por: Yin, Jianyong, et al.
Publicado: (2017)

Construction and validation of an early warning model for predicting the acute kidney injury in elderly patients with sepsis
por: Xin, Qi, et al.
Publicado: (2022)

Effect of antithrombin III on inflammatory immune response in patients with severe sepsis
por: Inthorn, D, et al.
Publicado: (1998)

SerpinC1/Antithrombin III in kidney-related diseases
por: Lu, Zeyuan, et al.
Publicado: (2017)

Use of antithrombin III in cancer patients with sepsis complicated with disseminated intravascular coagulopathy
por: Polansky, M, et al.
Publicado: (1998)

Antithrombin III concentrate may contribute to sepsis in nonovert disseminated intravascular coagulation
por: Saito, Noriko, et al.
Publicado: (2013)

Sepsis-Induced Coagulopathy and Japanese Association for Acute Medicine DIC in Coagulopathic Patients with Decreased Antithrombin and Treated by Antithrombin
por: Iba, Toshiaki, et al.
Publicado: (2018)

Antithrombin and free tri-iodothyronine in sepsis
por: Mateu, P, et al.
Publicado: (2004)

Inhibition of HCV by the serpin antithrombin III
por: Asmal, Mohammed, et al.
Publicado: (2012)

Proper diagnosis of antithrombin III deficiency
por: Özdemir, Zehra Narlı, et al.
Publicado: (2017)

Antithrombin and hypercoagulability in sepsis: insights from thrombelastography?
por: Hoffmann, Johannes N, et al.
Publicado: (2007)

Antithrombin III Protects Against Contrast-Induced Nephropathy
por: Lu, Zeyuan, et al.
Publicado: (2017)

Biomarkers of Sepsis-Induced Acute Kidney Injury
por: Wang, Kaifei, et al.
Publicado: (2018)

Reduction of D-dimer levels after therapeutic administration of antithrombin in acquired antithrombin deficiency of severe sepsis
por: Kountchev, Jordan, et al.
Publicado: (2005)

Sepsis-Associated DIC with Decreased Levels of Antithrombin and Fibrinogen is the Target for Combination Therapy with Thrombomodulin Alfa and Antithrombin
por: Wada, Hideo, et al.
Publicado: (2023)

Inhibition of neutrophil migration by the serpin antithrombin III
por: Dunzendorfer, S, et al.
Publicado: (2000)

Deficiency Of Antithrombin III (AT III) - Case Report and Review of the Literature
por: GĂMAN, AMELIA MARIA, et al.
Publicado: (2014)

Risk factors and a prediction model for sepsis: A multicenter retrospective study in China()
por: Li, Ming, et al.
Publicado: (2022)

Decreased Protein C, Protein S and Antithrombin III Levels are predictive of poor outcome in Gram-negative sepsis caused by Burkholderia pseudomallei
por: Larosa, SP, et al.
Publicado: (2000)

Efficacy of antithrombin administration in the acute phase of burn injury
por: Lavrentieva, A, et al.
Publicado: (2008)

Relationship between protein C and antithrombin III deficiencies in sepsis without disseminated intravascular coagulation status
por: Takeda, Munekazu, et al.
Publicado: (2008)

Comparison of Antithrombin III and Pentoxifylline Treatments in Gram Negative Sepsis Patients Developing Disseminated Intravascular Coagulation
por: Ozden, Mesure Gul Nihan, et al.
Publicado: (2019)

Efficacy of Serum Antithrombin III Test in Patients With Severe Traumatic Brain Injury
por: Noh, HeeSeung, et al.
Publicado: (2023)

Adequate Antithrombin III Level Predicts Survival in Severe COVID-19 Pneumonia
por: Joshi, Deepti, et al.
Publicado: (2021)

Quality of life effects of antithrombin III in sepsis survivors: results from the KyberSept trial [ISRCTN22931023]
por: Rublee, Dale, et al.
Publicado: (2002)

Specific deactivation of monocyte and lymphocyte migration by antithrombin III
por: Reinisch, C, et al.
Publicado: (2001)

Strategy for Cardiovascular Surgery in Patients with Antithrombin III Deficiency
por: Nishimura, Yoshiyuki, et al.
Publicado: (2018)

Effect of Immobilized Antithrombin III on the Thromboresistance of Polycarbonate Urethane
por: Lukas, Karin, et al.
Publicado: (2017)

Antithrombin III/SerpinC1 insufficiency exacerbates renal ischemia/reperfusion injury
por: Wang, Feng, et al.
Publicado: (2015)

Impact of Antithrombin Activity Levels Following Recombinant Antithrombin Gamma Therapy in Patients with Sepsis-Induced Disseminated Intravascular Coagulation
por: Akahoshi, Tomohiko, et al.
Publicado: (2022)

Prediction of Early Death in Patients With Sepsis-Associated Coagulation Disorder Treated With Antithrombin Supplementation
por: Iba, Toshiaki, et al.
Publicado: (2018)

A Predictive Model Based on Inflammatory and Coagulation Indicators for Sepsis-Induced Acute Kidney Injury
por: Xin, Qi, et al.
Publicado: (2022)

Clinical review: Molecular mechanisms underlying the role of antithrombin in sepsis
por: Wiedermann, Christian J
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_6a0jp3i6l4n970msmc0v9tcc2v